Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-04

Clinical Trial Update: Effect of Preoperative Intravenous Ferric Carboxymaltose for Clipping Surgery [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating preoperative intravenous ferric carboxymaltose to manage iron deficiency anemia in patients undergoing clipping surgery for unrupture…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ferric carboxymaltose (ferric carboxymaltose)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Cerebral Aneurysm Unruptured, Iron Deficiency Anemia | Phase 4 | Status: UNKNOWN